American Capital Advisory’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17K | Sell |
1,954
-1,954
| -50% | -$1.17K | ﹤0.01% | 474 |
|
|
2025
Q1 | $1.06K | Buy |
3,908
+1,954
| +100% | +$528 | ﹤0.01% | 424 |
|
|
2024
Q4 | $1.02K | Hold |
1,954
| – | – | ﹤0.01% | 421 |
|
|
2024
Q3 | $6.33K | Buy |
1,954
+754
| +63% | +$2.44K | ﹤0.01% | 330 |
|
|
2024
Q2 | $4.97K | Hold |
1,200
| – | – | ﹤0.01% | 304 |
|
|
2024
Q1 | $2.71K | Hold |
1,200
| – | – | ﹤0.01% | 350 |
|
|
2023
Q4 | $4.97K | Buy |
+1,200
| New | +$4.97K | ﹤0.01% | 304 |
|